- Home
- CREG vs CVKD Comparison
CREG vs CVKD Comparison
Compare CREG & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREG
- CVKD
- Stock Information
- Founded
- CREG 1980
- CVKD 2022
- Country
- CREG China
- CVKD United States
- Employees
- CREG N/A
- CVKD N/A
- Industry
- CREG Power Generation
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- CREG Utilities
- CVKD Health Care
- Exchange
- CREG Nasdaq
- CVKD Nasdaq
- Market Cap
- CREG 6.0M
- CVKD 20.8M
- IPO Year
- CREG N/A
- CVKD 2023
- Fundamental
- Price
- CREG $0.65
- CVKD $16.17
- Analyst Decision
- CREG
- CVKD Strong Buy
- Analyst Count
- CREG 0
- CVKD 2
- Target Price
- CREG N/A
- CVKD $46.00
- AVG Volume (30 Days)
- CREG 33.9K
- CVKD 79.1K
- Earning Date
- CREG 11-08-2024
- CVKD 11-07-2024
- Dividend Yield
- CREG N/A
- CVKD N/A
- EPS Growth
- CREG N/A
- CVKD N/A
- EPS
- CREG N/A
- CVKD N/A
- Revenue
- CREG N/A
- CVKD N/A
- Revenue This Year
- CREG N/A
- CVKD N/A
- Revenue Next Year
- CREG N/A
- CVKD N/A
- P/E Ratio
- CREG N/A
- CVKD N/A
- Revenue Growth
- CREG N/A
- CVKD N/A
- 52 Week Low
- CREG $0.57
- CVKD $5.40
- 52 Week High
- CREG $2.00
- CVKD $32.55
- Technical
- Relative Strength Index (RSI)
- CREG 41.81
- CVKD 61.78
- Support Level
- CREG $0.57
- CVKD $10.65
- Resistance Level
- CREG $0.72
- CVKD $12.25
- Average True Range (ATR)
- CREG 0.06
- CVKD 1.68
- MACD
- CREG -0.01
- CVKD 0.32
- Stochastic Oscillator
- CREG 38.05
- CVKD 76.54
About CREG Smart Powerr Corp.
Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company currently offer waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.